Remisson rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
| Original language | English |
|---|---|
| Journal | Annals of the Rheumatic Diseases |
| Volume | 71 |
| Issue number | 3 suppl. |
| Pages (from-to) | 360-1 |
| Number of pages | 2 |
| ISSN | 0003-4967 |
| Publication status | Published - 2012 |
ID: 48463052